LYNKUET Drug Patent Profile
✉ Email this page to a colleague
When do Lynkuet patents expire, and when can generic versions of Lynkuet launch?
Lynkuet is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in LYNKUET is elinzanetant. One supplier is listed for this compound. Additional details are available on the elinzanetant profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LYNKUET?
- What are the global sales for LYNKUET?
- What is Average Wholesale Price for LYNKUET?
Summary for LYNKUET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in LYNKUET? | LYNKUET excipients list |
| DailyMed Link: | LYNKUET at DailyMed |
US Patents and Regulatory Information for LYNKUET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | LYNKUET | elinzanetant | CAPSULE;ORAL | 219469-001 | Oct 24, 2025 | RX | Yes | Yes | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
